The decision by any institution on the selected host cell line impacts the quality, cost of goods, and speed of the development process.
Through this poster, the Samsung Biologics CDO R&D Team describes our accelerated platform, cell line development, and the compelling study outcome of its new proprietary cell line.
With our fast development timeline by 3 months and significantly high titer results from our proprietary cell line, Samsung Biologics provides our partners an option to proceed to IND Faster & Better.
The decision by any institution on the selected host cell line impacts the quality, cost of goods, and speed of the development process.
Through this poster, the Samsung Biologics CDO R&D Team describes our accelerated platform, cell line development, and the compelling study outcome of its new proprietary cell line.
With our fast development timeline by 3 months and significantly high titer results from our proprietary cell line, Samsung Biologics provides our partners an option to proceed to IND Faster & Better.
- Attached
Share article
Related Content